QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Coverage Initiated by Taglich Brothers
Coverage of Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has been initiated by Taglich Brothers, Inc., a full-service broker dealer focused exclusively on microcap companies. Taglich Brothers offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community. To request access to the complete 20-page report on Trxade Group, visit www.TaglichBrothers.com.
About Trxade Group, Inc. Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.